What it is & primary uses
A cartilage-related compound studied mainly for knee osteoarthritis, with results that depend heavily on formulation and trial quality.
Main benefits
- A specific prescription crystalline sulfate form may modestly improve knee symptoms
- Results do not transfer automatically to glucosamine hydrochloride or blends
Studied protocols
Research doses are grouped by outcome. They describe study designs—not a personal prescription.
1,500 mg/day crystalline glucosamine sulfate
- Study duration
- At least 8–12 weeks
- Interpretation
- The formulation is part of the evidence. Results should not be transferred automatically to glucosamine hydrochloride or mixed joint products.
04Food sources & equivalents＋
Can food provide a studied amount?
Glucosamine is manufactured from shellfish shells or by fermentation; edible shellfish meat does not provide a measured equivalent dose.
No validated 1,500 mg crystalline glucosamine sulfate serving
- How this was estimated
- No calculation is shown because shell material, glucosamine base and sulfate-salt mass are not interchangeable.
- Important limitation
- Source allergy and formulation matter. Prescription crystalline sulfate evidence does not transfer automatically to glucosamine hydrochloride or mixed products.
Food equivalents compare ingredient mass using published composition values. They do not prove equal absorption, formulation, physiological effect, safety or personal need.
Source: NCCIH glucosamine evidence and safety summary ↗05How to take it for absorption & tolerance＋
With food
Knee-osteoarthritis studies use once-daily crystalline glucosamine sulfate; no special meal is responsible for the reported outcome.
- Practical approach
- Take with a meal if nausea or heartburn occurs, and verify sulfate versus hydrochloride on the label.
- Watch for
- Warfarin users need professional review because increased bleeding risk has been reported.
Meal guidance reflects human pharmacokinetic, clinical, official-label or evidence-review sources where available. A food pairing can change absorption or tolerability, but does not make a supplement necessary, effective or safe for every person.
Source: NCCIH glucosamine evidence and safety summary ↗06Supplement interaction check＋
An unlisted pair means no established pair-specific interaction was identified in this review—not proof that every dose, product or person is safe.
This is not proof that every dose, product or user context is safe. Medication and condition checks still apply.
07Research notes＋
Moderate only for prescription crystalline glucosamine sulfate in knee osteoarthritis; retail formulations and clinical guidelines remain inconsistent.
Major clinical guidelines disagree. The positive evidence is most specific to prescription crystalline glucosamine sulfate, not every retail glucosamine product.
08Scientific references＋
Peer-reviewed human research and formal evidence reviews. Open each source to inspect the complete paper record.
Glucosamine sulfate umbrella review
Dose context: Almost all trials used 1,500 mg/day
Reported benefits for selected knee-osteoarthritis outcomes, especially with prescription crystalline glucosamine sulfate, without more adverse events than placebo.
Glucosamine sulfate for knee osteoarthritis
Dose context: 1,500 mg once daily for 12 weeks
Reported less pain and better function in a 60-person trial, with similar adverse-event rates.
NCCIH glucosamine and chondroitin evidence review
Dose context: Multiple formulations and trials
Finds results and guidelines conflicting and warns about warfarin-associated bleeding risk and possible glucose effects.
09Expert & media references＋
Podcast and practitioner statements are clearly separated from research. They may explain practice or emerging ideas, but do not prove efficacy.